Author

Allison M. Dyevoich

The University of Texas MD Anderson Cancer CenterORCID 0000-0002-4106-0435Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Akata SahaiD· 1 shared Bhakti PateliD· 1 shared Jing WangiD· 1 shared Josue Estiven PinedaiD· 1 shared Li SheniD· 1 shared Matthew M. GubiniD· 1 shared Morgan Riba· 1 shared Sarah M. SchneideriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Akata SahaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyThe Journal of ImmunologyPeer-reviewedAug 1, 2026

Antigen presentation requirements for effective cDC1-based cancer immunotherapy

Josue Estiven Pineda, Tomoyuki Minowa, Li Shen…·Matthew M. Gubin

This study shows that in vitro-derived cDC1s resemble tumor-infiltrating DCs and that MHC-I and MHC-II antigen presentation by these cells is essential for effective cancer immunotherapy.

DOI 10.1093/jimmun/vkag198

mousehuman

𝕏 PostBluesky